Global Fish Vaccine Market to Surpass US$ 413.41 Million by 2030, Says Coherent Market Insights (CMI)

Pune, INDIA


Seattle, Aug. 29, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights analysis, the global fish vaccine market is estimated to be valued at US$ 249.20 Million in 2022 and is expected to exhibit a CAGR of 6.5% during the forecast period (2022-2030).

Key Trends and Analysis of the Global Fish Vaccine Market:

Key trends in the market include increasing product launches or approvals, increasing collaborations by market players, and increasing acquisitions.

The increasing launches of new fishes vaccines is expected to propel the growth of the global fish vaccine market over the forecast period. For instance, in 2021, the Indian Council of Agricultural Research - Central Institute of Brackishwater Aquaculture (ICAR-CIBA) launched CIBA-Nodavac-R, a recombinant vaccine against viral nervous necrosis (VNN) which affects many marine, brackish water, and freshwater fish, causing up to 100% mortality in larval and early juvenile stages. CIBA-Nodavac-R is an injectable recombinant VNN vaccine, and it has shown to prevent VNN, which is caused by Red-spotted grouper nervous necrosis virus (RGNNV) in fingerlings and thus prevent vertical transmission in brooders.

Market players are involved in strategies such as collaborations, which is expected to drive the growth of the global fish vaccine market over the forecast period. For instance, in 2019, PHARMAQ, a company involved in in vaccines and innovation for aquaculture collaborated with AFRY, an experienced pharmaceutical company, in order to increase the capacity of the manufacturing process, from inoculation, fermentation of the vaccine to the deactivation process.

Market players are involved in strategies such as acquisitions, which is expected to drive the growth of the global fish vaccine market. For instance, in July 2020, Zoetis, global animal health company announced the acquisition of Fish Vet Group from Benchmark Holdings, PLC, an aquaculture biotechnology company as a strategic addition to its Pharmaq business, which develops and commercializes fish vaccines and provides aquaculture vaccination and diagnostic services.

Request Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/5184

Key Market Takeaways:

The increasing presence of companies in aquaculture is expected to augment the market growth over the forecast period. For instance, in 2017, HIPRA, a pharmaceutical company, increased its presence in aquaculture by expanding its presence in other countries such as the U.K. and Ireland, as well as the Nordic countries. The company is currently developing vaccines for salmon fish.

Competitive Landscape:

Key players operating in the global fish vaccine market include HIPRA, VETERQUIMICA SA, Ictyogroup, Kyoto Biken Laboratories, Inc., Vaxxinova International BV, Barramundi Group, Merck & Co., Inc., Zoetis Inc., KBNP, INC., Aqua Vet S.A., and NISSEIKEN CO., LTD

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/5184

Market Segmentation:

  • Global Fish Vaccine Market, By Vaccine Type:
    • Killed Vaccine
    • Inactivated Vaccine
    • Attenuated Vaccine
    • Toxoid Vaccine
    • Subunit Vaccine
    • Conjugate Vaccine
    • Recombinant Vector Vaccines
  • Global Fish Vaccine Market, By Indication:
    • Furunculosis
    • Vibriosis
    • Yersiniosis
    • Enteric septicaemia
    • Others
  • Global Fish Vaccine Market, By Route of Administration:
    • Injection
    • Immersion
    • Spray
    • Oral
  • Global Fish Vaccine Market , By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa

Related Market Intelligence Reports:

Swine Fever Vaccine Market, by Type (African Swine Fever and Classical Swine Fever), by Vaccine Type (Live-Attenuated, Chimeric (Live-attenuated or inactivated), Subunit or vector system based, and Replicon vaccine), by Distribution Channel (Public and Private), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030

Typhoid Fever Vaccines Market, by Vaccine Type (Live Attenuated Vaccine, Capsular Polysaccharide Vaccines, Conjugate Vaccine, and Others), by Route of Administration (Oral and Parental), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Follow Us: LinkedInTwitter

 

Contact Data